Illumina Can't Revive DNA-Sequencing Patent Claims
A California federal judge on Wednesday refused to reconsider her prior art invalidation of nine method claims regarding a DNA-sequencing method patent owned by Illumina Inc., ruling that the company didn't...To view the full article, register now.
Already a subscriber? Click here to view full article